Christine Jenkins's Publications
About Christine Jenkins's Publications
Program Head, Respiratory- Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
- Clinical Professor, Concord Clinical School, University of Sydney
- AM,
- MD,
- FRACP,
- FThor ,
- Soc ,
- FAAHMS
-
Cardiovascular Comorbidity in Chronic Lung Disease: Gender Differences
Cardiac Considerations in Chronic Lung Disease Date published: -
Sex and gender in health research: updating policy to reflect evidence
Medical Journal of Australia Date published: -
S102 Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial
COPD: inflammation, smoking and exacerbations Date published: -
S29 The impact of GOLD stage on the effectiveness of tiotropium/olodaterol in preventing COPD exacerbations in the DYNAGITO trial
What’s new? Clinical trials in lung disease Date published: -
Too little, too late? The underuse of beta-blockers in COPD needs evidence to address clinical uncertainty
Respirology Date published: -
COPD EXACERBATION RATE BY BASELINE COPD ASSESSMENT TEST SCORE IN THE DYNAGITO STUDY
CHEST Date published: -
Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
ERJ Open Research Date published: -
Azithromycin add-on therapy reduces airway inflammation and extracellular DNA: An AMAZES sub-study
Airway pharmacology and treatment Date published: -
Eosinophil counts as a predictor of future COPD exacerbations in the DYNAGITO trial
Monitoring airway disease Date published: -
Regional analysis of COPD exacerbation rates in the DYNAGITO trial
Monitoring airway disease Date published: -
People With COPD Who Respond to Ground-Based Walking Training Are Characterized by Lower Pre-training Exercise Capacity and Better Lung Function and Have Greater Progression in Walking Training Distance
Journal of Cardiopulmonary Rehabilitation and Prevention Date published: -
Overdiagnosis of COPD in Subjects With Unobstructed Spirometry
CHEST Date published: -
Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma
American Journal of Respiratory and Critical Care Medicine Date published: -
A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma
Journal of Allergy and Clinical Immunology Date published: -
The Frequency of Exacerbations Treated with Antibiotics, Steroids or Both Differs by GOLD Stage in Patients with COPD in the DYNAGITO Trial
A102. COPD: THERAPY Date published: -
Seasonal Pattern of COPD Exacerbations in the DYNAGITO Trial
C32. COPD: TRANSLATIONAL AND MECHANISTIC STUDIES Date published: